Sjogren's Syndrome is a chronic autoimmune disorder that affects the body's moisture-producing glands. It is characterized by dry eyes and mouth, fatigue, joint pain, and other symptoms. It can be difficult to diagnose, as it often presents with symptoms similar to other conditions. As a result, many people go undiagnosed for years. This article will explore the mysteries of Sjogren's Syndrome, its diagnosis, and new treatment options.
Sjogren's Syndrome is an autoimmune disorder, meaning the body’s immune system mistakenly attacks healthy cells and tissues. In this case, the immune system attacks the moisture-producing glands, which can cause dry eyes and mouth. Other symptoms may include fatigue, joint pain, dry skin, and difficulty swallowing. It is estimated that up to 4 million Americans have Sjogren's Syndrome, although many go undiagnosed for years.
Diagnosing Sjogren's Syndrome can be difficult, as the symptoms can be similar to other conditions. As a result, it is important to consult with a doctor if you are experiencing any of the symptoms listed above. A doctor will likely perform a physical exam to check for signs of dryness, such as dry eyes or mouth. They may also order blood tests to look for antibodies that are associated with Sjogren's Syndrome. In some cases, a doctor may order a biopsy of the salivary glands to confirm a diagnosis.
There is no cure for Sjogren's Syndrome, but there are treatments available to help manage the symptoms. These include medications, such as anti-inflammatory drugs and immune system suppressants, as well as lifestyle changes, such as drinking more fluids and avoiding dry environments. Additionally, there are a few newer treatments that are being explored.
Stem cell therapy is a promising new treatment for Sjogren's Syndrome. Stem cells are cells that have the potential to develop into any type of cell in the body. In the case of Sjogren's Syndrome, stem cells are injected into the affected glands, where they can help to repair and regenerate the damaged tissue. This can help to improve the symptoms of dryness and reduce inflammation.
Plasma exchange is another new treatment option for Sjogren's Syndrome. In this procedure, a patient's blood is removed and filtered, and the plasma is replaced with donor plasma. The goal of this treatment is to reduce the levels of antibodies in the blood that are attacking the glands. This can help to reduce inflammation and improve symptoms.
Sjogren's Syndrome is a chronic autoimmune disorder that can cause dry eyes and mouth, fatigue, joint pain, and other symptoms. Diagnosing Sjogren's Syndrome can be difficult, as the symptoms can be similar to other conditions. There is no cure for Sjogren's Syndrome, but there are treatments available to help manage the symptoms. Additionally, there are a few newer treatments, such as stem cell therapy and plasma exchange, that are being explored. With new treatments, we are closer to unlocking the mysteries of Sjogren's Syndrome.
1.
Certain surgical gestures during prostate removal linked to better sexual function recovery
2.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
3.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
4.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
5.
Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
What Is A Normal Fibrinogen Level, And How Can It Affect Your Health
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation